Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
36%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
19
HOLDINGS
37%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 18.0% | 12.5% | 12.5% | |
| ASTRAZENECA PLC-SPONS ADR | 5.5% | 5.0% | 5.0% | |
| ABBVIE INC | 8.5% | 4.7% | 4.7% | |
| AMGEN INC | 3.9% | 6.5% | 3.9% | |
| MERCK & CO. INC. | 3.7% | 5.3% | 3.7% | |
MEDX Overweight Relative to THNR
| NOVARTIS AG-ADR | 6.8% | |
| ELI LILLY & CO | 5.4% | |
| IONIS PHARMACEUTICALS, INC. | 5.0% | |
| ALNYLAM PHARMACEUTICALS INC | 5.0% | |
| JOHNSON & JOHNSON | 4.9% | |
| BRISTOL-MYERS SQUIBB CO | 4.7% | |
| ABBVIE INC | 3.8% | |
| ALKERMES PLC | 3.4% | |
| BIOGEN IDEC INC | 2.9% | |
| CRISPR THERAPEUTICS AG | 2.9% |
MEDX Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -14.0% | |
| CHUGAI PHARMACEUTICAL CO LTD | -6.3% | |
| ROCHE HOLDING LTD | -5.1% | |
| SHIONOGI & CO LTD | -5.1% | |
| INNOVENT BIOLOGICS, INC. | -5.0% | |
| CHINA PHARMACEUTICAL GROUP | -4.1% | |
| REGENERON PHARMACEUTICALS | -3.9% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -3.8% | |
| HIMS & HERS HEALTH, INC. CLASS A | -3.0% | |
| AMGEN INC | -2.7% |